
Gene Therapy Offers New Hope for Chronic Pain Without Addiction Risk
University of Pennsylvania researchers develop first brain-targeted gene therapy that mimics morphine's pain relief without triggering reward pathways, offering potential breakthrough for 50 million Americans living with chronic pain.







